A specific dietary intervention to restore brain structure and function after ischemic stroke

Theranostics

Volumn 7, Issue 2, 2017, Pages 493-512

  Wiesmann, Maximilian ^a   Zinnhardt, Bastian ^b   Reinhardt, Dirk ^b   Eligehausen, Sarah ^b   Wachsmuth, Lydia ^b   Hermann, Sven ^b   Dederen, Pieter J ^a   Hellwich, Marloes ^a   Kuhlmann, Michael T ^b   Broersen, Laus M ^c   Heerschap, Arend ^a   Jacobs, Andreas H ^b,d   Kiliaan, Amanda J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c DANONE NUTRICIA RESEARCH   (Netherlands)

^d Johanniter Krankenhaus   (Germany)

Author keywords

Animal model; Cerebral blood flow; Cerebral connectivity; Cerebral ischemia; MRI; Neuroinflammation; PET

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CARRIER PROTEIN; CELL PROTEIN; CHOLINE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; DOUBLECORTIN; FOLIC ACID; GLUCOSE TRANSPORTER 1; ICOSAPENTAENOIC ACID; IONIZED CALCIUM BINDING ADAPTER MOLECULE 1 PROTEIN; PHOSPHOLIPID; POSTSYNAPTIC DENSITY PROTEIN 95; PYRIDOXINE; SELENIUM; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; URIDINE; FORTASYN CONNECT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN STRUCTURE RESTORATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET THERAPY; DIFFUSION TENSOR IMAGING; FOOD INTAKE; FORTASYN DIET; FRACTIONAL ANISOTROPY; FUNCTIONAL CONNECTIVITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRIP STRENGTH TEST; MALE; MEAN DIFFUSIVITY; MOTOR PERFORMANCE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPEN FIELD TEST; PHYSICAL PARAMETERS; POLE TEST; POSITRON EMISSION TOMOGRAPHY; THERAPY EFFECT; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; DIAGNOSTIC IMAGING; DISEASE MODEL; LOCOMOTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; STROKE; TREATMENT OUTCOME;

ANIMALS; BEHAVIOR, ANIMAL; DIET THERAPY; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; LOCOMOTION; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; PHOSPHOLIPIDS; POSITRON-EMISSION TOMOGRAPHY; STROKE; TREATMENT OUTCOME;

EID: 85017247070     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.17559     Document Type: Article

References (93)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2095-128.
2. (CDC) CfDCaP. Prevalence and most common causes of disability among adults--United States, 2005. MMWR Morb Mortal Wkly Rep. 2009; 58: 421-6.
3. Lyden P. Thrombolytic Therapy for Acute Stroke - Not a Moment to Lose. N Engl J Med. 2008; 359: 1393-5.
4. Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology. 2008; 55: 310-8.
5. Hong S-H, Belayev L, Khoutorova L, Obenaus A, Bazan NG. Docosahexaenoic acid confers enduring neuroprotection in experimental stroke. J Neurol Sci. 2014; 338: 135-41.
6. MEMBERS WG, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. Executive Summary: Heart Disease and Stroke Statistics-2010 Update: A Report From the American Heart Association. Circulation. 2010; 121: 948-54.
7. Rost NS, Bottle A, Lee JM, Randall M, Middleton S, Shaw L, et al. Stroke Severity Is a Crucial Predictor of Outcome: An International Prospective Validation Study. J Am Heart Assoc. 2016; 5.
8. Belayev L, Khoutorova L, Atkins KD, Eady TN, Hong S, Lu Y, et al. Docosahexaenoic Acid therapy of experimental ischemic stroke. Transl Stroke Res. 2011; 2: 33-41.
9. Rutten-Jacobs LC, Arntz RM, Maaijwee NA, Schoonderwaldt HC, Dorresteijn LD, van Dijk EJ, et al. Long-term mortality after stroke among adults aged 18 to 50 years. JAMA. 2013; 309: 1136-44.
10. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart Disease and Stroke Statistics-2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008.
11. Jacobs AH, Tavitian B, consortium tI. Noninvasive Molecular Imaging of Neuroinflammation. J Cereb Blood Flow Metab. 2012; 32: 1393-415.
12. Aquilani R, Scocchi M, Boschi F, Viglio S, Iadarola P, Pastoris O, et al. Effect of calorie-protein supplementation on the cognitive recovery of patients with subacute stroke. Nutr Neurosci. 2008; 11: 235-40.
13. Aquilani R, Scocchi M, Iadarola P, Franciscone P, Verri M, Boschi F, et al. Protein supplementation may enhance the spontaneous recovery of neurological alterations in patients with ischaemic stroke. Clin Rehabil. 2008; 22: 1042-50.
14. Gardener H, Wright CB, Gu Y, Demmer RT, Boden-Albala B, Elkind MS, et al. Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr. 2011; 94: 1458-64.
15. Nguemeni C, Delplanque B, Rovère C, Simon-Rousseau N, Gandin C, Agnani G, et al. Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol Res. 2010; 61: 226-33.
16. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, et al. Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke. 2004; 35: 1538-42.
17. Larsson SC, Virtamo J, Wolk A. Dietary fats and dietary cholesterol and risk of stroke in women. Atherosclerosis. 2012; 221: 282-6.
18. Thies F, Garry J, Yaqoob P, Rerkasem K, Williams J, Shearman CP, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003; 361: 477-85.
19. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002; 20: 1493-9.
20. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997; 336: 1046-53.
21. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002; 287: 1815-21.
22. von Schacky C, Harris WS. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res. 2007; 73: 310-5.
23. Ozen O, Cosar M, Sahin O, Fidan H, Eser O, Mollaoglu H, et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat prefrontal cortex. Neurol Sci. 2008; 29: 147-52.
24. Holguin S, Huang Y, Liu J, Wurtman R. Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats. Behav Brain Res. 2008; 191: 11-6.
25. von Schacky C. A Review of Omega-3 Ethyl Esters for Cardiovascular Prevention and Treatment of Increased Blood Triglyceride Levels. Vasc Health Risk Manag. 2006; 2: 251-62.
26. Song T-J, Chang Y, Shin M-J, Heo JH, Kim Y-J. Low levels of plasma omega 3-polyunsaturated fatty acids are associated with cerebral small vessel diseases in acute ischemic stroke patients. Nutr Res. 2015; 35: 368-74.
27. Holguin S, Martinez J, Chow C, Wurtman R. Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J. 2008; 22: 3938-46.
28. Wurtman RJ, Cansev M, Sakamoto T, Ulus I. Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses. Nutr Rev. 2010; 68: S88-S101.
29. Weiss S, Kennedy E. The function of cytidine coenzymes in the biosynthesis of phospholipids. J Biol Chem. 1956; 222: 193.
30. Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, MarzloffG. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 2006; 1088: 83-92.
31. Cansev M, Wurtman RJ. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience. 2007; 148: 421-31.
32. Sakamoto T, Cansev M, Wurtman RJ. Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 2007; 1182: 50-9.
33. Zerbi V, Jansen D, Wiesmann M, Fang X, Broersen LM, Veltien A, et al. Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease. Neurobiol Aging. 2014; 35: 600-13.
34. Wiesmann M, Jansen D, Zerbi V, Broersen LM, Garthe A, Kiliaan AJ. Improved spatial learning strategy and memory in aged Alzheimer AbetaPPswe/PS1dE9 mice on a multi-nutrient diet. J Alzheimers Dis. 2013; 37: 233-45.
35. Wiesmann M, Zerbi V, Jansen D, Haast R, Lütjohann D, Broersen LM, et al. A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice. Neural Plast. 2016; 2016: 15.
36. Zerbi V, Jansen D, Wiesmann M, Fang X, Broersen LM, Veltien A, et al. Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease. Neurobiology of Aging. 2014; 35: 600-13.
37. Pallier PN, Poddighe L, Zbarsky V, Kostusiak M, Choudhury R, Hart T, et al. A nutrient combination designed to enhance synapse formation and function improves outcome in experimental spinal cord injury. Neurobiol Dis. 2015; 82: 504-15.
38. Chen M-K, Guilarte TR. Translocator Protein 18kDA (TSPO): Molecular Sensor of Brain Injury & Repair. Pharmacol Ther. 2008; 118: 1-17.
39. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère J-J, Lindemann P, et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006; 27: 402-9.
40. Jacobs AH, Tavitian B, the Ic. Noninvasive molecular imaging of neuroinflammation. J Cereb Blood Flow Metab. 2012; 32: 1393-415.
41. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol. 2010; 8: e1000412.
42. (STAIR) STAIR. Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development. Stroke. 1999; 30: 2752.
43. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations. Stroke. 2009; 40: 2244-50.
44. Boltze J, Wagner D-C, Henninger N, Plesnila N, Ayata C. Phase III Preclinical Trials in Translational Stroke Research: Community Response on Framework and Guidelines. Transl Stroke Res. 2016; 7: 241-7.
45. Engel O, Kolodziej S, Dirnagl U, Prinz V. Modeling Stroke in Mice-Middle Cerebral Artery Occlusion with the Filament Model. J Vis Exp. 2011: e2423.
46. Zinnhardt B, Viel T, Wachsmuth L, Vrachimis A, Wagner S, Breyholz H-J, et al. Multimodal Imaging Reveals Temporal and Spatial Microglia and Matrix Metalloproteinase Activity after Experimental Stroke. J Cereb Blood Flow Metab. 2015; 35: 1711-21.
47. Endres M, Dirnagl U. Ischemia and Stroke. In: Alzheimer C, editor. Molecular and Cellular Biology of Neuroprotection in the CNS. Boston, MA: Springer US; 2002: 455-73.
48. Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gómez-Isla T, et al. Attenuation of Delayed Neuronal Death after Mild Focal Ischemia in Mice by Inhibition of the Caspase Family. J Cereb Blood Flow Metab. 1998; 18: 238-47.
49. Fink K, Zhu J, Namura S, Shimizu-Sasamata M, Endres M, Ma J, et al. Prolonged Therapeutic Window for Ischemic Brain Damage Caused by Delayed Caspase Activation. J Cereb Blood Flow Metab. 1998; 18: 1071-6.
50. Popp A, Jaenisch N, Witte OW, Frahm C. Identification of Ischemic Regions in a Rat Model of Stroke. PLoS ONE. 2009; 4: e4764.
51. Carmichael ST. Rodent Models of Focal Stroke: Size, Mechanism, and Purpose. NeuroRx. 2005; 2: 396-409.
52. Jansen D, Zerbi V, Arnoldussen IAC, Wiesmann M, Rijpma A, Fang XT, et al. Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in AßPPswe-PS1dE9 Mice. PLoS ONE. 2013; 8: e75393.
53. Jansen D, Zerbi V, Janssen CF, van Rooij D, Zinnhardt B, Dederen P, et al. Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice. Brain Struct Funct. 2014; 219: 1841-68.
54. Janssen CIF, Zerbi V, Mutsaers MPC, de Jong BSW, Wiesmann M, Arnoldussen IAC, et al. Impact of dietary n-3 polyunsaturated fatty acids on cognition, motor skills and hippocampal neurogenesis in developing C57BL/6J mice. J Nutr Biochem. 2015; 26: 24-35.
55. Janssen CIF, Zerbi V, Mutsaers MPC, Jochems M, Vos CA, Vos JO, et al. Effect of perinatally supplemented flavonoids on brain structure, circulation, cognition, and metabolism in C57BL/6J mice. Neurochem Int. 2015; 89: 157-69.
56. Streijger F, Oerlemans F, Ellenbroek BA, Jost CR, Wieringa B, Van der Zee CEEM. Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit. Behav Brain Res. 2005; 157: 219-34.
57. Hooijmans CR, Van der Zee CEEM, Dederen PJ, Brouwer KM, Reijmer YD, van Groen T, et al. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol Dis. 2009; 33: 482-98.
58. Lange N, Hamann M, Shashidharan P, Richter A. Behavioural and pharmacological examinations in a transgenic mouse model of early-onset torsion dystonia. Pharmacol Biochem Behav. 2011; 97: 647-55.
59. Balkaya M, Endres M. Behavioral Testing in Mouse Models of Stroke. In: Dirnagl U, editor. Rodent Models of Stroke: Humana Press; 2010: 179-97.
60. Kim SG. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med. 1995; 34: 293-301.
61. Kwong KK, Chesler DA, WeisskoffRM, Donahue KM, Davis TL, Ostergaard L, et al. MR perfusion studies with T1-weighted echo planar imaging. Magn Reson Med. 1995; 34: 878-87.
62. Paxinos G, Franklin KB. The mouse brain in stereotaxic coordinates/George Paxinos, Keith Franklin. London: Academic; 2004.
63. Harsan LA, Paul D, Schnell S, Kreher BW, Hennig J, Staiger JF, et al. In vivo diffusion tensor magnetic resonance imaging and fiber tracking of the mouse brain. NMR Biomed. 2010; 23: 884-96.
64. Zerbi V, Kleinnijenhuis M, Fang X, Jansen D, Veltien A, Van Asten J, et al. Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model. Neurobiol Aging. 2013; 34: 1440-50.
65. Zwiers MP. Patching cardiac and head motion artefacts in diffusion-weighted images. Neuroimage. 2010; 53: 565-75.
66. Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA. Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neurobiol Dis. 2009; 33: 20-7.
67. Jonckers E, Van Audekerke J, De Visscher G, Van der Linden A, Verhoye M. Functional Connectivity fMRI of the Rodent Brain: Comparison of Functional Connectivity Networks in Rat and Mouse. PLoS ONE. 2011; 6: e18876.
68. James ML, Fulton RR, Vercoullie J, Henderson DJ, Garreau L, Chalon S, et al. DPA-714, a New Translocator Protein-Specific Ligand: Synthesis, Radiofluorination, and Pharmacologic Characterization. J Nucl Med. 2008; 49: 814-22.
69. Vollmar SCJ, Sue M, Klein J, Jacobs AH, Herholz K. VINCI-Volume Imaging in Neurological Research, Co-Registration and ROIs Forschung und wissenschaftliches Rechnen 2003. Göttingen: Gesellschaft für Wissenschaftliche Datenverarbeitung; 2004: 115-31.
70. Janssen CIF, Jansen D, Mutsaers MPC, Dederen PJWC, Geenen B, Mulder MT, et al. The Effect of a High-Fat Diet on Brain Plasticity, Inflammation and Cognition in Female ApoE4-Knockin and ApoE-Knockout Mice. PLoS ONE. 2016; 11: e0155307.
71. Dirnagl U, Hakim A, Macleod M, Fisher M, Howells D, Alan SM, et al. A concerted appeal for international cooperation in preclinical stroke research. Stroke. 2013; 44: 1754-60.
72. Dirnagl U, Fisher M. International, multicenter randomized preclinical trials in translational stroke research: It's time to act. J Cereb Blood Flow Metab. 2012; 32: 933-5.
73. Le Bihan D, Mangin J-F, Poupon C, Clark CA, Pappata S, Molko N, et al. Diffusion tensor imaging: Concepts and applications. J Magn Reson Imaging. 2001; 13: 534-46.
74. Alexander AL, Hurley SA, Samsonov AA, Adluru N, Hosseinbor AP, Mossahebi P, et al. Characterization of Cerebral White Matter Properties Using Quantitative Magnetic Resonance Imaging Stains. Brain Connect. 2011; 1: 423-46.
75. Feldman HM, Yeatman JD, Lee ES, Barde LHF, Gaman-Bean S. Diffusion Tensor Imaging: A Review for Pediatric Researchers and Clinicians. J Dev Behav Pediatr. 2010; 31: 346-56.
76. Salvati S, Natali F, Attorri L, Di Benedetto R, Leonardi F, Di Biase A, et al. Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain. J Neurosci Res. 2008; 86: 776-84.
77. Grayson DS, Kroenke CD, Neuringer M, Fair DA. Dietary Omega-3 Fatty Acids Modulate Large-Scale Systems Organization in the Rhesus Macaque Brain. J Neurosci. 2014; 34: 2065-74.
78. de Waal H, Stam CJ, Lansbergen MM, Wieggers RL, Kamphuis PJGH, Scheltens P, et al. The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer?s Disease: A Randomised Controlled Study. PLoS ONE. 2014; 9: e86558.
79. Park C-h, Chang WH, Ohn SH, Kim ST, Bang OY, Pascual-Leone A, et al. Longitudinal Changes of Resting-State Functional Connectivity During Motor Recovery After Stroke. Stroke. 2011; 42: 1357-62.
80. Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience. 2006; 139: 991-7.
81. Martín A, Boisgard R, Thézé B, Van Camp N, Kuhnast B, Damont A, et al. Evaluation of the PBR/TSPO Radioligand [18F]DPA-714 in a Rat Model of Focal Cerebral Ischemia. J Cereb Blood Flow Metab. 2010; 30: 230-41.
82. Vivash L, O'Brien TJ. Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases? J Nucl Med. 2016; 57: 165-8.
83. Lavisse S, Guillermier M, Hérard A-S, Petit F, Delahaye M, Van Camp N, et al. Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging. J Neurosci. 2012; 32: 10809-18.
84. Harvey LD, Yin Y, Attarwala IY, Begum G, Deng J, Yan HQ, et al. Administration of DHA Reduces Endoplasmic Reticulum Stress-Associated Inflammation and Alters Microglial or Macrophage Activation in Traumatic Brain Injury. ASN Neuro. 2015; 7: 1759091415618969.
85. Nimmerjahn A, KirchhoffF, Helmchen F. Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo. Science. 2005; 308: 1314-8.
86. Tremblay M-È, Lowery RL, Majewska AK. Microglial Interactions with Synapses Are Modulated by Visual Experience. PLoS Biol. 2010; 8: e1000527.
87. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic Pruning by Microglia Is Necessary for Normal Brain Development. Science. 2011; 333: 1456-8.
88. Kurtys E, Eisel ULM, Verkuyl JM, Broersen LM, Dierckx RAJO, de Vries EFJ. The combination of vitamins and omega-3 fatty acids has an enhanced anti-inflammatory effect on microglia. Neurochem Int. 2016; 99: 206-14.
89. Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016; 16: 51-67.
90. Heras-Sandoval D, Pedraza-Chaverri J, Pérez-Rojas JM. Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease. J Neuroinflammation. 2016; 13: 61.
91. Bourourou M, Heurteaux C, Blondeau N. Alpha-linolenic acid given as enteral or parenteral nutritional intervention against sensorimotor and cognitive deficits in a mouse model of ischemic stroke. Neuropharmacology. 2016; 108: 60-72.
92. Boltze J, Lukomska B, Jolkkonen J, consortium M-I. Mesenchymal Stromal Cells in Stroke: Improvement of Motor Recovery or Functional Compensation? J Cereb Blood Flow Metab. 2014; 34: 1420-1.
93. Wang M, IliffJJ, Liao Y, Chen MJ, Shinseki MS, Venkataraman A, et al. Cognitive deficits and delayed neuronal loss in a mouse model of multiple microinfarcts. J Neurosci. 2012; 32: 17948-60.